Gabriel Ricolleau

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Pascal Jézéquel, Mario Campone, Wilfried Gouraud et al. · Breast Cancer Research and Treatment · 2011 · 425 citations

Prognostic Biomarkers, Breast Oncology, Engineering +13

bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses

P. Jezequel, Jean‐Sébastien Frenel, L. Campion et al. · Database · 2013 · 273 citations · Full text

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

Jean‐Marc Riedinger, J Wafflart, Gabriel Ricolleau et al. · Annals of Oncology · 2006 · 101 citations · Full text

Ca 125, Medicine, Cancer Management +8

Surface‐enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node‐negative breast cancer tumors

Gabriel Ricolleau, Catherine Guérin‐Charbonnel, Laurence Lodé et al. · PROTEOMICS · 2006 · 94 citations

Ferritin Light Chain, Breast Oncology, Engineering +20